Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.2B |
| 2 |
Apple
AAPL
|
+$2.07B |
| 3 |
RTX Corp
RTX
|
+$1.99B |
| 4 |
Amazon
AMZN
|
+$1.27B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1.03B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.03B |
| 2 |
Expedia Group
EXPE
|
+$903M |
| 3 |
Uber
UBER
|
+$600M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$521M |
| 5 |
Shopify
SHOP
|
+$455M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.57% |
| 2 | Technology | 21.3% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.92% |
| 5 | Consumer Discretionary | 9.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Kura Oncology
KURA
$1.04B
| $19.1M | ﹤0.01% |
1,330,955
+1,169,992
| +727% | +$11.5M |
|
2727
Nuveen Municipal High Income Opportunity Fund
NMZ
$2.03B
| $19.1M | ﹤0.01% |
1,934,119
-69,646
| -3% | -$650K |
|
2728
Evolent Health
EVH
$417M
| $19.1M | ﹤0.01% |
578,435
-40,711
| -7% | -$1.15M |
|
2729
Enovix
ENVX
$656M
| $19.1M | ﹤0.01% |
1,743,766
-1,040,083
| -37% | -$10.2M |
|
2730
Fox Factory Holding Corp
FOXF
$789M
| $19.1M | ﹤0.01% |
282,367
-4,861
| -2% | -$355K |
|
2731
Titan Machinery
TITN
$558M
| $19M | ﹤0.01% |
659,424
+132,543
| +25% | +$3.43M |
|
2732
Upbound Group
UPBD
$999M
| $19M | ﹤0.01% |
560,112
+147,515
| +36% | +$4.39M |
|
|
ACH
2733
Accendra Health
ACH
$68.4M
| $19M | ﹤0.01% |
984,544
+172,983
| +21% | +$3.13M |
|
2734
Northwest Natural Holdings
NWN
$2.03B
| $19M | ﹤0.01% |
486,750
+37,207
| +8% | +$1.41M |
|
|
STR
2735
DELISTED
Sitio Royalties
STR
| $18.9M | ﹤0.01% |
805,791
+229,173
| +40% | +$5.32M |
|
2736
Beazer Homes USA
BZH
$889M
| $18.9M | ﹤0.01% |
560,616
-195,397
| -26% | -$5.34M |
|
2737
CareDx
CDNA
$2.78B
| $18.9M | ﹤0.01% |
1,578,228
+897,839
| +132% | +$7.36M |
|
2738
Nu Skin
NUS
$223M
| $18.9M | ﹤0.01% |
974,883
-129,025
| -12% | -$2.38M |
|
2739
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.36B
| $18.9M | ﹤0.01% |
174,175
-81,646
| -32% | -$7.81M |
|
|
SAGE
2740
DELISTED
Sage Therapeutics
SAGE
| $18.9M | ﹤0.01% |
870,564
+6,632
| +0.8% | +$131K |
|
2741
Maplebear
CART
$10.5B
| $18.8M | ﹤0.01% |
801,721
+665,429
| +488% | +$16.7M |
|
2742
PIMCO Enhanced Short Maturity Active ESG ETF
EMNT
$221M
| $18.8M | ﹤0.01% |
191,996
+80,949
| +73% | +$7.93M |
|
2743
iShares Global Consumer Staples ETF
KXI
$1.06B
| $18.8M | ﹤0.01% |
317,084
+38,895
| +14% | +$2.24M |
|
2744
Santander
BSBR
$43.1B
| $18.8M | ﹤0.01% |
2,870,206
+1,279,492
| +80% | +$7.54M |
|
2745
Maravai LifeSciences
MRVI
$1.04B
| $18.8M | ﹤0.01% |
2,869,148
+1,442,909
| +101% | +$9.32M |
|
2746
BioCryst Pharmaceuticals
BCRX
$2.22B
| $18.8M | ﹤0.01% |
3,136,688
+1,310,864
| +72% | +$7.6M |
|
|
NXDT
2747
NexPoint Diversified Real Estate Trust
NXDT
$271M
| $18.8M | ﹤0.01% |
2,363,337
+199,200
| +9% | +$1.63M |
|
2748
Ramaco Resources Class A
METC
$587M
| $18.8M | ﹤0.01% |
1,129,758
+1,082,852
| +2,309% | +$15M |
|
|
CHY
2749
Calamos Convertible and High Income Fund
CHY
$1B
| $18.8M | ﹤0.01% |
1,634,969
-103,361
| -6% | -$1.17M |
|
2750
XPEL
XPEL
$1.23B
| $18.7M | ﹤0.01% |
346,504
+21,796
| +7% | +$1.17M |
|
Similar funds
Morgan Stanley's Q4 2023 Portfolio in Review
As of Q4 2023, Morgan Stanley held 8,094 positions worth $1.13T, up 15% from $983B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Morgan Stanley deployed $37.4B of net new capital in Q4 2023, opening 478 new positions and adding to 4,064 existing holdings. Its largest new stake was Birkenstock: 2,348,072 shares worth $114M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Expedia Group, an estimated $903M trimmed.
- Morgan Stanley's largest Q4 2023 buy was Birkenstock: 2,348,072 shares worth $114M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $4.2B increase.
- Morgan Stanley's biggest Q4 2023 reduction was Expedia Group, cutting an estimated $903M.
- Morgan Stanley fully exited Activision Blizzard in Q4 2023, selling an estimated $1.03B.
- Morgan Stanley's ten largest holdings make up 18% of its $1.13T portfolio in Q4 2023.
- Morgan Stanley opened 478 new positions and closed 270 in Q4 2023.
- Morgan Stanley's portfolio value rose 15% quarter-over-quarter to $1.13T.
Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.